Benefits and Risks Key takeaways: Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity
How PlexusDx structures its own pricing PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, spanning Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, and a microdose option at a flat $129 per month, alongside oral formats
In addition, a large number of clinical studies have shown that GLP-/GIP dual agonists can reduce LFC, VAT, and body weight, and have an improvement effect on both NAFLD and NASH [131,132]
Willow did not respond or issue an Advertisers Statement regarding NADs decision, which led NAD to refer the matter to the appropriate regulatory authorities, including state Attorneys General